Through potent inhibition of BET-bromodomain (BET-BD) interactions, we previously reported that OPN5 significantly impairs CLL B cell proliferation and demonstrates profound antitumor effects in Eμ-TCL1 mice (12). This evidence concerns the gene OPN5 and B-cell chronic lymphocytic leukemia.